HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Umbilical cord blood transplantation from unrelated HLA-matched donor in an adult with severe aplastic anemia.

Abstract
A 23-year-old male suffering from severe aplastic anemia (SAA) weighing 60 kg was successfully treated by unrelated allo-CBSCT (cord blood stem cell transplantation). A six-loci HLA-identical umbilical cord blood (UCB) was infused after conditioning with low-dose cyclophosphamide (CTX) and antilymphocyte globulin (ALG). The prophylaxis of GVHD consisted of CsA and MTX. The infused cord blood provided 1.89 x 10(7) nucleated cells per kg, CD34-positive cells: 0.89%. Neutrophils >0.5 x 10(9)/l were reached 10 days after transplant, and platelets greater than 50.0 x 10(9)/l at day 26. RBC and platelet transfusion independence were reached on days 15 and 18. The patient developed grade 1 skin GVHD 10 months after engraftment of the donor cells. Microsatellite DNA fingerprinting indicated a stable and persistent donor-recipient mixed chimerism, whilst the circulating red cells remain of host origin.
AuthorsP Mao, C Liao, Z Zhu, H Wang, S Wang, Y Xu, W Mo, Y Ying, Q Li, B Liu
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 26 Issue 10 Pg. 1121-3 (Nov 2000) ISSN: 0268-3369 [Print] England
PMID11108315 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Anemia, Aplastic (therapy)
  • Fetal Blood (cytology)
  • Graft vs Host Disease (etiology)
  • Hematopoietic Stem Cell Transplantation
  • Histocompatibility Testing
  • Humans
  • Male
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: